Quick Takeaways:
- Cardiometabolic dysfunction is the earliest measurable expression of chronic disease risk. It captures the convergence of metabolic, vascular, and inflammatory pathways long before clinical events occur.
- Insulin resistance and visceral adiposity are core drivers, often progressing silently for years before heart disease, stroke, or type 2 diabetes are diagnosed.
- Preventive cardiology has shifted upstream. Early cardiometabolic screening, beginning at age 35, and earlier for higher-risk individuals, enables intervention at a stage when risk is still modifiable.
- The greatest opportunity in medicine lies in early, strategic prevention. Evidence-based lifestyle interventions, complemented by precision diagnostics and targeted therapies, can meaningfully alter your long-term health trajectory.
- At Personal Health MD, cardiometabolic care is proactive, personalized, and data-informed, integrating advanced testing with deeply individualized risk assessment and prevention strategies.
How’s Your Cardiometabolic Health?
Are you concerned about your risk for heart disease, stroke, or diabetes? If you’re only monitoring traditional labs like cholesterol and blood sugar, you may be overlooking earlier drivers of disease.
We now understand that insulin resistance, excess intra-abdominal (visceral) fat, and chronic inflammation can impair vascular function and accelerate cardiovascular disease decades before symptoms appear. These metabolic disturbances often compound over time, quietly increasing long-term risk.
For this reason, cardiometabolic dysfunction now sits at the center of modern preventive cardiology.
What Is Cardiometabolic Dysfunction?
Cardiometabolic dysfunction is a whole-body condition in which disturbances in metabolism, including insulin resistance, visceral fat accumulation, and chronic inflammation, increase risk for heart disease, stroke, and type 2 diabetes.
The process frequently begins in visceral adipose tissue, the deeper fat surrounding internal organs. Unlike subcutaneous fat, visceral fat is metabolically active. It releases inflammatory signals that can damage blood vessels, the heart, kidneys, and liver, and reduce insulin sensitivity while disrupting blood sugar regulation.
Over time, this “insulin resistance” may progress into recognizable clinical conditions, including:
- Metabolic syndrome
- Prediabetes
- Hypertension
- Dyslipidemia (elevated cholesterol and/or triglycerides)
- Metabolic-associated fatty liver disease (MAFLD)
Preventive cardiology increasingly focuses on these upstream drivers of disease, recognizing the central role of lifestyle, environment, and behavior in long-term cardiovascular health.
Why Cardiometabolic Dysfunction Matters
Most people don’t develop “just” diabetes or “just” high blood pressure. Metabolic, vascular, and inflammatory processes overlap and amplify one another over time.
Rather than waiting for advanced cardiovascular disease to emerge, a cardiometabolic framework prioritizes earlier identification and earlier intervention. This shift allows us to act when prevention is most effective, before irreversible damage occurs.
Should You Be Tested for Cardiometabolic Dysfunction?
Adults aged 35 and older should undergo periodic screening for cardiometabolic dysfunction, with frequency matched to individual risk factors and health goals.
For individuals without additional risk factors, screening every three years is generally appropriate. Earlier and more frequent testing (every one or two years) is recommended for those with overweight or obesity (BMI >25, or >23 in individuals of Asian ancestry) and one or more of the following:
- First-degree relative with diabetes and/or a personal history of diabetes, prediabetes, or gestational diabetes
- Family history of premature heart disease (men <55 years, women <65 years)
- Higher-risk race/ethnicity (Black, Latino, Native American, Asian American)
- Hypertension (blood pressure >130/80 mmHg or on medication)
- Low HDL (“good”) cholesterol (<35 mg/dL) and/or elevated triglycerides (>150 mg/dL)
- Polycystic ovary syndrome [PCOS] (newly renamed Polyendocrine Metabolic Ovarian Syndrome [PMOS])
- Obstructive sleep apnea
- Physical inactivity
- Metabolic dysfunction-associated fatty liver disease (MAFLD)
Cardiometabolic risk is rarely defined by a single lab value. It results from the cumulative interaction of genetics, metabolic function, and lifestyle. Thoughtful screening provides clarity at a stage when meaningful prevention is still possible.
The Personal Health MD Cardiometabolic Risk Assessment
At Personal Health MD, cardiometabolic evaluations are individualized based on your clinical history, risk profile, and long-term goals.
A baseline assessment typically includes:
- Detailed medical history, risk review, and physical examination
- Blood pressure assessment
- Body composition analysis
- Resting electrocardiogram (EKG)
- Lifestyle assessment (nutrition, physical activity, sleep, stress)
- Laboratory testing, often including:
- Lipid panel
- Fasting glucose and A1c
- Liver and kidney function testing
- Additional targeted biomarkers as appropriate
For patients seeking deeper risk assessment or with established risk factors, advanced diagnostics may include:
- Advanced lipid testing (ApoB, Lp(a), LDL particle number and size)
- Inflammation markers (hsCRP, homocysteine, uric acid)
- Home blood pressure trend analysis
- Continuous glucose monitoring or oral glucose tolerance testing
- Coronary Artery Calcium (CAC) scoring
- Coronary CT Angiography (CCTA), including AI-enhanced analysis
- Liver imaging and elastography
These tools allow us to identify subclinical disease, often years before conventional testing shows abnormalities.
A Personalized Approach to Cardiometabolic Health
The first concierge medicine practice in Boston to offer Cleerly AI-enhanced CCTA and Boston Heart Diagnostics curated testing, Personal Health MD remains at the forefront of cardiometabolic medicine. We’re passionate about bringing the most advanced evidence-based technologies and treatments into our care.
Our approach combines advanced diagnostics with evidence-based lifestyle medicine and, when appropriate, targeted therapies. Depending on individual needs, care may include:
- Lifestyle strategies (nutrition, physical activity, sleep, stress management)
- Personalized weight management support
- Therapies to improve insulin sensitivity and glucose regulation
- Blood pressure optimization to protect vascular and kidney health
- Lipid-lowering therapies, including statins, PCSK9 inhibitors, and newer agents when indicated
- Behavioral coaching to support sustainable change
Cardiometabolic optimization is not about chasing isolated numbers. It is about aligning preventive medicine with your physiology, values, and long-term goals.
Our role is to help you understand your risk clearly and act early.
Ready for a Clearer Picture of Your Cardiometabolic Health?
A thorough cardiometabolic assessment offers clarity, direction, and an opportunity for proactive prevention.
If you’re seeking a personalized plan that integrates advanced diagnostics with evidence-based lifestyle and medical strategies, Personal Health MD is here to help.
To schedule an appointment or learn more, visit the Personal Health MD website or call 617-585-1500.
Dr. Lisa McGonigal is a board-certified Family, Preventive, and Lifestyle Medicine physician with advanced training in Diabetes Management and Clinical Nutrition and a special interest in Menopause Management, and Preventive Cardiology. She earned her MD from West Virginia University and her MPH from George Washington University, then completed fellowship training in Preventive and Lifestyle Medicine at the University of Massachusetts Medical School. Dr. McGonigal joined Personal Health MD to bring her prevention-focused approach to concierge care and is currently accepting new patients.
